Optic Neuritis Associated With Tumor Necrosis Factor–Alpha Inhibitor Certolizumab

Autor:	Neil R. Miller, Ariel Chen, Thomas M. Bosley
Rok vydání:	2020
Předmět:	Pathology medicine.medical_specialty Optic Neuritis Tumor Necrosis Factor-alpha business.industry medicine.disease Certolizumab Ophthalmology Certolizumab Pegol medicine Humans Immunologic Factors Optic neuritis Tumor necrosis factor alpha Neurology (clinical) business
Zdroj:	Journal of Neuro-Ophthalmology. 41:e713-e714
ISSN:	1070-8022
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68ec66b56c9b3ebe207211cf10abfd5 https://doi.org/10.1097/wno.0000000000001150 Zobrazit plný text záznamu